SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/09/24 NeuBase Therapeutics, Inc. DEF 14A 5/13/24 1:1M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: DEF 14A Definitive Proxy Statement HTML 384K
tm249597-2_def14a - none - 3.7500159s |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 14 | | | |
| | | | 28 | | | |
| | | | 29 | | | |
| | | | 31 | | | |
| | | | 31 | | | |
| | | | 31 | | | |
| | | | 31 | | | |
| | | | A-1 | | | |
| | | | B-1 | | |
Name and address of Beneficial Owner
|
| |
Number of Shares
Beneficially Owned |
| |
Percentage of
Class (%)(1) |
| ||||||
5% Stockholders | | | | | | | | | | | | | |
Dietrich A. Stephan, Ph.D., Director and Former Chief Executive
Officer(2) |
| | | | 244,028 | | | | | | 6.5% | | |
Other Directors and Named Executive Officers(3) | | | | | | | | | | | | | |
Todd P. Branning, Interim Chief Executive Officer and Chief Financial Officer(4)
|
| | | | 21,040 | | | | | | * | | |
Dov A. Goldstein, M.D., Chairperson(5)
|
| | | | 15,632 | | | | | | * | | |
Gerald J. McDougall, Director(6)
|
| | | | 5,552 | | | | | | * | | |
Eric I. Richman, Director(7)
|
| | | | 16,379 | | | | | | * | | |
All current executive officers and directors as a group (five persons)(8)
|
| | | | 302,631 | | | | | | 7.9% | | |
This ‘DEF 14A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
For Period end: | 5/13/24 | PRE 14A | ||
5/12/24 | ||||
5/1/24 | ||||
4/23/24 | ||||
Filed on: | 4/9/24 | |||
3/28/24 | ||||
3/7/24 | 8-K | |||
3/5/24 | 8-K | |||
2/29/24 | ||||
2/23/24 | 8-K | |||
2/22/24 | 8-K | |||
1/31/24 | ||||
1/26/24 | 8-K | |||
1/17/24 | 8-K | |||
12/28/23 | 424B3, 8-K | |||
12/27/23 | 8-K | |||
12/22/23 | 8-K | |||
11/9/23 | 10-Q | |||
11/6/23 | 8-K | |||
11/3/23 | 8-K | |||
10/20/23 | 8-K | |||
10/18/23 | 8-K | |||
9/30/23 | 10-Q | |||
9/29/23 | 8-K | |||
9/18/23 | 4, 8-K, DEFA14A | |||
8/14/23 | 10-Q | |||
8/3/23 | 8-K, UPLOAD | |||
7/31/23 | 8-K | |||
6/30/23 | 10-Q, 424B3, 424B5, 8-K | |||
6/14/23 | 8-K | |||
6/5/23 | 10-QT | |||
5/18/23 | 8-K | |||
5/11/23 | 10-Q, 8-K | |||
4/24/23 | 8-K | |||
3/31/23 | 10-Q | |||
3/29/23 | 8-K | |||
2/14/23 | 10-Q, 8-K | |||
12/31/22 | 10-Q, 10-QT, 5 | |||
12/29/22 | 424B5, 8-K | |||
12/21/22 | 10-K, 8-K | |||
10/24/22 | 8-K | |||
10/14/22 | 8-K | |||
10/3/22 | 8-K | |||
10/1/22 | ||||
9/30/22 | 10-K, 4, ARS | |||
4/21/21 | 424B5, 8-K | |||
12/28/20 | ||||
10/2/20 | 8-K | |||
List all Filings |